Field of Work
Monilola Olayioye's research on the biological function of growth factor receptors has laid an important foundation for the development of targeted approaches in personalized cancer medicine. Tumor cells are characterized by complex molecular changes that lead to increased growth and motility. With her team, Monilola Olayioye investigates the interplay of tumor suppressive and oncogenic signaling networks in cellular transformation. A particular focus is on signaling pathways that contribute to cancer cell metastasis. In 3D tissue culture models the molecular interactions with the tumor cell environment are studied in order to identify new therapeutic intervention strategies.
Monilola Olayioye, born 1972 in London, was the first to be awarded a Heisenberg professorship by the DFG in Molecular Tumor Cell Biology at the University of Stuttgart in 2011. Before then, Monilola Olayioye was an independent research group leader at the Institute of Cell Biology and Immunology at the University of Stuttgart and an EMBO postdoctoral fellow at the Walter and Eliza Hall Institute in Melbourne. She completed her diploma studies of biotechnology from Technical University of Braunschweig at the Scripps Research Institute in San Diego and earned her PhD at the Friedrich Miescher Institute in Basel. From 2019 to 2021 Monilola Olayioye served as Vice Rector for Early Career Researchers and Diversity and as a member of the Research Council of the University of Stuttgart. She furthermore heads Biomedical Systems, defined as an emerging research field at the University of Stuttgart.